News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /CNW/ — As lawmakers weigh potential cuts to scientific research ...

A new pilot clinical study will explore the safety and effectiveness of 2 anti-canine monoclonal antibodies on solid tumors ...

Food insecurity is linked to a 28% higher risk of death among cancer survivors compared with those who have never received a ...

In the scrublands and home gardens of Sri Lanka, where fire-orange blooms dance in the tropical heat, a quiet revolution is ...

RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers ...

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves—insights ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

The response rate to Amtagvi was higher in patients who had received two or fewer therapies than in those with more heavily ...

Although relatively rare, many childhood cancers remain life-threatening and lack effective personalized treatments. Rhabdoid tumors are among these fatal cancers and can develop in various tissues ...

Understanding chronic inflammation and how to control it could help people live healthier, longer lives. This study shows that keeping the immune system in balance is key to preventing damage and ...

As a medical oncologist, one of the first threats I inform new patients about during the informed consent process for cancer ...